10 Digital Health Companies Seeking Distributors and Hospital Partners for Smart Surgery, Digital Diagnostics, and Health Management Solutions
VCBeat
Internet Medical Health Media
- VCBeat’s “Supply-Demand Matching” Industry Linkage Platform: Efficiently Connects Industry Resources to Drive Performance Growth
- To date, VCBeat has launched nearly 1,000 links, with each link receiving exposure1W+, achieving over successful enterprise matchings2,000 times
- Continuously curate and publish collections of selected links, with precise distribution to VCBeat’s relevant professional communities (total reach exceeding3W+）
In recent years, with the gradual maturation and widespread application of new-generation information technologies such as cloud computing, the Internet of Things (IoT), mobile internet, big data, artificial intelligence (AI), 5G networks, and blockchain, informatization has become a key driver in promoting the construction of modern healthcare service systems and the transformation and innovation of medical service models. Amidst the wave of digitalization and intelligence, various new models, new business formats, new technologies, and new services continue to emerge, ushering in unprecedented changes in the healthcare sector.
The multiple medical device products previously selected for our audience have effectively facilitated connections between distributors and manufacturersHundreds of timesConnection Successful. The VCBeat Link Platform is designed to help enterprises precisely reach their target partners. If your enterprise has innovative medical products and wishes to participate in the weekly link promotion program, pleaseScan the QR code at the end of the articleAdd Assistant for Consultation.
In this issue, we have carefully selected for you10 Innovative Healthcare Solutions, seeking high-quality channel partners, hospitals, and other market collaborators. Details are as follows:
Yizhiying Technology - One-Stop Solution for Tumor Radiotherapy
● Company/Product Introduction:
Founded in July 2019, Yizhiying is a medical AI company dedicated to developing “Precision Oncology Treatment Solutions” leveraging medical big data and artificial intelligence technologies. The company focuses on clinical target volume (CTV) delineation for oncology treatment. It has completed CTV delineation solutions for breast cancer, rectal cancer, cervical cancer, lung cancer, esophageal cancer, total marrow irradiation (TMI), and pediatric tumors, as well as fully automated delineation for over 120 organs at risk (OARs) throughout the body. Its independently developed core products include the “RT-Mind Radiotherapy Contouring Software,” the “RT-Link Intelligent Radiotherapy Workflow Management System,” and the “RT-Solution Integrated Intelligent Radiotherapy Solution.” Building on these foundations, the company has established a planning navigation product portfolio covering multiple anatomical sites and diseases—including the heart, lungs, and liver—thereby forming a comprehensive product matrix.
One-Stop Solution for Tumor Radiotherapy: Software- and AI-Driven Precision Radiotherapy to Achieve Automation in Oncology Radiation Therapy. Features Include Automatic Contouring, Automatic Planning, and Automatic Quality Control, with FDA Clearance.
● Requirements Description:
Seeking overseas distributors, agent resources, and international investment promotion.
Lida Pioneer - Automated Drug Target Histone Preparation System
● Company/Product Introduction:
Lida Lead is China’s first and one of the world’s pioneering biotechnology companies based on chemical proteomics technology, as well as the world’s first company to successfully automate a drug discovery platform using chemical proteomics. Lida Lead has mastered the world’s most advanced chemobiology technologies, enabling rapid screening of early-stage novel drugs in human living cells through its proteomic “target fishing probe” technology.
Leveraging its leading position in the field of chemical proteomics, Litada Pioneer launched the world’s first fully automated chemical proteomics sample preparation system—“Target Space Station”—in October 2023, establishing its market leadership within the industry. This system represents an innovative solution for drug development, designed to accelerate the discovery of drug targets and the screening of novel target ligands.
● Requirement Description:
Seeking collaborative partners such as pharmaceutical companies and research institutions.
Airmidi-MOST Smart Integrated Surgical Solution Technology Platform
●Company/ProductIntroduction：
Airymed is a national high-tech enterprise specializing in the R&D, production, and sales of core medical sensors and digital diagnostic and therapeutic equipment. Centered on intelligent digital diagnostic and therapeutic devices such as surgical robots and medical imaging systems, it provides a full range of integrated smart surgery solutions.
Leveraging its comprehensive capabilities in R&D, testing, clinical trials, and regulatory approval, Airui Maidi has established a product development and technical implementation system for one-stop smart surgery solutions, centered on the MOST R&D framework. This system addresses the need for high-precision positioning throughout the entire surgical process. With core navigation components as the focal point of business implementation, the company has built a technical implementation system for one-stop smart surgery solutions, offering a diverse portfolio that includes surgical robots, intelligent imaging equipment, augmented reality simulation, intelligent motor rehabilitation, and intelligent physiological monitoring.
● Requirement Description：
Seeking distributors, hospitals, and other relevant partners.
Han's Union - Stem Cell Regenerative Medicine Technology
●Company/ProductIntroduction：
Beijing Health & Hope Biotechnology Co., Ltd. has established a comprehensive industry chain centered on stem cell regenerative medicine technologies. As a nationally recognized high-tech enterprise, Health & Hope has established six stem cell banks across China, all constructed and operational in compliance with Good Manufacturing Practice (GMP) standards. The company has also set up multiple stem cell R&D branches nationwide, providing high-level regenerative medicine research platforms for hospitals, universities, and research institutes both domestically and internationally. The group has developed a layout comprising more than 20 subsidiaries and established its European R&D center, H&B France, in France, with business operations covering both domestic and overseas markets.
In 2020, Han’s United established the Han’s Ark platform, a health protection initiative for entire families featuring stem cell technology. The platform encompasses five major sectors: Cell Storage, Han’s Medicine, My Cell Center, Bio-Skincare, and Cell Valley, aiming to create a customized health management center for the full life cycle.
● Requirement Description：
Recruiting ecosystem partners in the stem cell field, including enterprises, product distributors and agents, research institutes, and hospitals.
Hangzhou Tiancheng Technology - Digital Scent Solutions
● Company/ProductIntroduction：
Technical Roadmap: Provision of odor simulation, odor storage, precise odor release, directional transmission, integration with large AI models, and molecular fusion in the gaseous state.
It primarily focuses on the drug development phase, including target identification, drug screening, and molecular synthesis. AI can accelerate the drug discovery and design process through technologies such as data mining, machine learning, and deep learning, thereby improving R&D efficiency and success rates. Furthermore, AI plays a role in quality control, process optimization, and intelligent management during drug manufacturing, enhancing both production efficiency and product quality.
● Requirement Description：
Seeking Market Partners. Application Scenarios for AI Digital Scent Technology: Digital Healthcare and Health Management, Rehabilitation Therapy in Rehabilitation Hospitals, Personalized Chronic Disease Management, Beauty and Body Care, Traditional Chinese Medicine (TCM) Rehabilitation Centers, and TCM Health Management.
Jianjian Medical - IoT + Medical Laboratory Data Transmission and Intelligent Analysis Technology
● Company/ProductIntroduction：
Beijing Jianjian Medical Technology Co., Ltd. centers on its independently developed “AI Digital-Intelligent Health Brain” technology, forming an industrial ecosystem that integrates “digital platforms + intelligent hardware + refined operations” across the entire chain of “screening, testing, prevention, treatment, management, and rehabilitation.” Its application scenarios mainly include digital public health, integrated primary care clinics for chronic diseases, national health information platforms, close-knit medical consortia, geriatric rehabilitation, and weight management.
Implement full-process intelligent and standardized management of national basic public health services to optimize traditional workflows and enhance the efficiency and quality of service delivery. The system can be flexibly deployed in various settings, including hospitals, communities, and rural areas, to conduct public health physical examinations and Traditional Chinese Medicine (TCM) health management services. It supports synchronized operations across multiple regions and concurrent testing by multiple users, ensuring efficient and orderly on-site service delivery. Data is automatically collected, transmitted, and processed, with reports generated immediately after examination. The intelligent hardware features a multifunctional, integrated all-in-one design with wireless connectivity, making it portable and easy to store. The operating system adopts a one-touch design with multi-role management capabilities, offering greater intelligence and practicality.
● Requirements Description：
Seeking channel and other market partners.
Baiyi Huixin-DetecMicro® Vascular Interventional Surgery Planning Software
●Company/ProductIntroduction：
Baiyi Huixin has developed China’s first surgical planning software that integrates structural analysis with treatment selection. Its flagship product, DetecMicro(®) Vascular Intervention Surgical Planning Software, leverages medical imaging data to perform detailed analysis and interpretation of patients’ cardiovascular conditions, providing comprehensive assistance to clinicians in planning interventional procedures such as EVAR, TEVAR, and TAVI. In November last year, the product officially received approval for Class III domestic medical device registration from the National Medical Products Administration (NMPA) (Registration No.: Guo Xie Zhu Zhun 20233211596).
● Requirements Description：
① Provincial Strategic Cooperative Distributor: Responsible for product promotion and market coverage within the province.
② Precision Partners: Implement projects within the specified timeframe on a per-project basis.
Ruijian Pharma -iReOrgan has independent intellectual property rights.
Chemically Induced Organoid Platform
Ruijian Pharma has established an integrated organoid R&D platform (iReOrgan) based on “AI + chemical induction.” The organoid models generated by this platform not only provide disease phenotypes but also reflect the spatiotemporal progression of diseases, making them a scarce offering in the current market. The existing iReOrgan platform has achieved scalable cultivation and developed a series of complex organoids and their derived disease models, including whole-brain organoids, midbrain organoids, and cardiac organoids. This enables high-throughput screening and validation of candidate drugs to be conducted simultaneously with model construction.
● Requirements Description：
The Ruijian iReOrgan platform offers a wide range of scientific research and industrial services, and welcomes collaborative projects with relevant research institutions and enterprises.
YiNao Tech – A Brain-Computer System Dedicated to Brain Health Care and Training
Chongqing Tongjian Smart Medical Technology Co., Ltd. is a digital and intelligent medical laboratory operations service provider. Leveraging “Tongjian,” an integrated Internet-plus-laboratory service platform, the company consolidates diverse testing resources to deliver personalized, one-stop, whole-course digital and intelligent laboratory and diagnostic services to individual users, internet healthcare providers, and health service organizations.
Objective: Build a “30-Minute Laboratory and Imaging Testing Circle” and establish the user mindset of “For tests, choose Tongjian.”
To ensure service stability, security, accessibility, and other requirements, we are now seeking partnerships.
● Requirement Description：
Scope of Partner Institutions:
Formal medical institutions equipped with laboratories (public/private hospitals, including specialized hospitals such as dental and ophthalmic hospitals; community health service institutions; outpatient clinics; departmental laboratories), third-party testing laboratories, etc.
IVD Manufacturers: Self-Testing, Mail-In Testing, and On-Site Testing Products and Services.
① Interested in the above companies' products, or currently monitoring products in other sectors
② If you have innovative medical products and wish to participate in the weekly linkage promotion program
Scan the QR code below to contact us.
- VCBeat’s Supply-Demand Matching Platform Covers: Global Expansion, Supply Chain, Marketing/Channels, Technology Transfer, and Investment Promotion & Onboarding
- Upload supply or demand resources via the platform to precisely reach target potential partners
- Efficiently connect with entities such as MNCs, startups, government industrial parks, and investment institutions
>>>>
Download the VCBeat App to publish content independently and connect efficiently.
